Humabiologics: Funding, Investors & Team (Sep 2026)
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers. Currently, the availability of human-derived biomaterials for regenerative therapies and research is limited due to unstable supply channels, low quality, and high prices. Humabiologics is dedicated to extending the gift of donation by developing and commercializing high quality, supply-stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. By stretching the gift of donation we strive to help as many people as possible with our unique products.
Humabiologics has raised $700k across 1 funding round on record, the most recent a Seed of $700k announced in Jan 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Humabiologics Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Humabiologics Funding Rounds
Humabiologics Founders and Leadership Team
Contact details for the Humabiologics team: 1 of 1 has an email address on file.
Start 14-day free trial →Humabiologics Funding Compared to Other Biotechnology Startups
Humabiologics' latest round of $700k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Humabiologics in Biotechnology and Phoenix
Companies Similar to Humabiologics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Humabiologics Funding FAQs
What does Humabiologics do?
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers. Currently, the availability of human-derived biomaterials for regenerative therapies and research is limited due to unstable supply channels, low quality, and high prices. Humabiologics is dedicated to extending the gift of donation by developing and commercializing high quality, supply-stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. By stretching the gift of donation we strive to help as many people as possible with our unique products.
How much funding has Humabiologics raised?
Humabiologics has raised $700k across 1 round on record. The most recent is a Seed of $700k announced in Jan 2022.
When did Humabiologics last raise funding?
Humabiologics' most recent funding round on record is a Seed of $700k, announced in Jan 2022.
Who is the CEO of Humabiologics?
Mohammad Albanna is listed as CEO at Humabiologics.
Where is Humabiologics headquartered?
Humabiologics is based in Phoenix, Arizona, United States.
How many employees does Humabiologics have?
Humabiologics is in the 1-10 employee band.
How does Humabiologics' funding compare to other Biotechnology startups?
Humabiologics' latest round of $700k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Humabiologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Humabiologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.